SEC Form 4 · accession 0001574774-19-000001
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather C Getz
Officer — Executive VP & CFO
Period of report
Jan 17, 2019
Accepted (ET)
Jan 22, 2019 · 9:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 17, 2019 | M | 8,236 | $2.54 | A | 88,797 | D | |
| Common StockF2 | Jan 17, 2019 | S | 8,236 | $70.01 | D | 80,561 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F3 | $2.54 | Jan 17, 2019 | M | 8,236 | D | — | Feb 19, 2023 | Common Stock | 8,236 | 39,272 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.25, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3The stock options vested in four equal annual installments, which began on December 31, 2013. The options were fully exercisable as of December 31, 2016.